New Delhi, April 15 (IANS) Healthcare companies in India are expected to deliver high single-digit revenue growth (year-on-year) in the fourth quarter of FY26 (Q4 FY26), a report showed on Wednesday.However, EBITDA margins will materially be corrected, according to the report by Systematix.“Median growth is estimated at 12 per cent for revenue and 3.6 per cent for EBTIDA, with net earnings likely witnessing a 14 per cent decline, the report mentioned.The primary driver of this on-year decline …
Latest Cipla News & Updates
Mumbai, April 3 (IANS) Indian equity markets closed lower for the sixth consecutive week amid escalating geopolitical tensions in West Asia and sharp currency fluctuations, with both headline indices ending in the red during a shortened four-day trading week.Sensex ended at 73,319.55 on Thursday, down 263.67 points or 0.35 per cent, compared to the previous Friday’s close. Nifty 50 settled at 22,713.10, a decline of 106.50 points or 0.46 per cent on a week-on-week basis.In the final session of t…
New Delhi, March 8 (IANS) A US-based subsidiary of Cipla has recalled more than 400 cartons of a generic anti-cancer medicine due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).In its latest enforcement report, the US health regulator said that Cipla USA, Inc, based in Warren, New Jersey, is recalling certain batches of Nilotinib Capsules in two strengths — 150 mg and 200 mg.The recall involves 271 cartons of one batch and 164 cartons of another batch of the …
Mumbai, Jan 28 (IANS) Indian equity benchmark indices Sensex and Nifty ended Wednesday’s session with modest gains, managing to stay in the green despite sharp volatility through the day. Investor sentiment was influenced by December-quarter earnings announcements and the finalisation of the India–European Union Free Trade Agreement.The Sensex closed at 82,345, rising 487 points, or 0.60 per cent. During the session, the index moved between a high of 82,504 and a low of 81,815 as markets swu…
New Delhi, Jan 26 (IANS) Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).In its Enforcement Report, the US health regulator said the US-based arm of Mumbai-headquartered Sun Pharma is recalling more than 26,000 bottles of a generic medicine used to treat dandruff and skin conditions that cause inflammation and itching.Sun…
New Delhi, Dec 26 (IANS) From changing the definition to the rise of GLP-1 medications, and the government’s several initiatives, especially Prime Minister Narendra Modi’s clarion call, obesity became the focus of healthcare in India in 2025.The anti-obesity drive, especially the generic drugs, will continue to remain a key focus in 2026.Traditionally, Body Mass Index (BMI) was used to define obesity, but after 15 long years, India revamped its obesity guidelines in 2025 by lowering the thresh…
Mumbai, Dec 26 (IANS) Indian benchmark indices opened flat with a mild negative bias on Friday, as markets are apparently in the consolidation phase amid lack of major cues.As of 9.30 am, Sensex edged down 83 points, or 0.09 per cent to 85,325 and Nifty eased 17 points, or 0.06 per cent to 26,124.Main broadcap indices outperformed benchmark indices in terms of gains, with the Nifty Midcap 100 advanced 0.35 per cent, while the Nifty Smallcap 100 added 0.27 per cent.Cipla, Dr Reddys Labs and ONGC …
Mumbai, Dec 24 (IANS) Indian benchmark indices made moderate gains early on Wednesday amid positive global cues, as the stock market appears to be in a consolidation phase.As of 9.30 am, Sensex advanced 105 points, or 0.12 per cent to 85,630 and Nifty gained 40 points, or 0.16 per cent to 26,217.Main broad-cap indices outperformed benchmark indices in terms of gains, with the Nifty Midcap 100 advanced 0.31 per cent, while the Nifty Smallcap 100 added 0.53 per cent.Hindalco Industries, Axis Bank …
Mumbai, Dec 22 (IANS) Indian benchmark indices opened in green zone on Monday, breaking the last week’s trend of edging lower, amid strong buying in the US and China markets.As of 9.30 am, the Sensex advanced 507 points, or 0.60 per cent, at 84,436 and the Nifty added 165 points, or 0.64 per cent to 26,132.The broad cap indices performed in line with the benchmarks, with the Nifty Midcap 100 up 0.58 per cent and the Nifty Smallcap 100 adding 0.51 per cent.Hindalco, Tech Mahindra and TCS were amo…